Corrigendum: The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy

Detalles Bibliográficos
Autores principales: Wang, Guanyun, Zhang, Wenwen, Luan, Xiaohui, Wang, Zhanbo, Liu, Jiajin, Xu, Xiaodan, Zhang, Jinming, Xu, Baixuan, Lu, Shichun, Wang, Ruimin, Ma, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241066/
https://www.ncbi.nlm.nih.gov/pubmed/37283748
http://dx.doi.org/10.3389/fimmu.2023.1219757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241066/
https://www.ncbi.nlm.nih.gov/pubmed/37283748
http://dx.doi.org/10.3389/fimmu.2023.1219757

Ejemplares similares